Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Current Assets (2020 - 2025)

Historic Current Assets for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $10.6 million.

  • Celularity's Current Assets fell 2693.42% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year decrease of 2693.42%. This contributed to the annual value of $20.6 million for FY2024, which is 388.02% up from last year.
  • Per Celularity's latest filing, its Current Assets stood at $10.6 million for Q3 2025, which was down 2693.42% from $17.3 million recorded in Q2 2025.
  • Celularity's 5-year Current Assets high stood at $91.3 million for Q3 2021, and its period low was $57811.0 during Q2 2021.
  • In the last 5 years, Celularity's Current Assets had a median value of $20.6 million in 2024 and averaged $31.7 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 13041668.37% in 2022, then plummeted by 7609.51% in 2023.
  • Celularity's Current Assets (Quarter) stood at $59.1 million in 2021, then crashed by 43.31% to $33.5 million in 2022, then crashed by 40.92% to $19.8 million in 2023, then increased by 3.88% to $20.6 million in 2024, then crashed by 48.47% to $10.6 million in 2025.
  • Its Current Assets was $10.6 million in Q3 2025, compared to $17.3 million in Q2 2025 and $22.1 million in Q1 2025.